Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie

Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie (GMI-HO) is a specialized German clinical research organization (CRO) focused on the fields of hematology and oncology. Based in Hamburg, the company provides comprehensive services for the planning, coordination, and execution of clinical trials, ranging from Phase I to Phase IV. GMI-HO acts as a strategic partner for both academic study groups and the pharmaceutical industry, facilitating the development of innovative cancer treatments. Their service portfolio includes project management, clinical monitoring, regulatory affairs, and data management tailored to the specific requirements of oncology research. By leveraging a deep network of clinical sites and therapeutic expertise, GMI-HO supports the advancement of medical innovation within the German healthcare system. The organization is particularly known for its involvement in high-quality investigator-initiated trials and complex industry-sponsored programs.